Shashank Shekhar,Thaddeus S. Franczyk,David M. Barnes,Travis B. Dunn,Anthony R. Haight,Vincent S. Chan
申请号：
US13591090
公开号：
US20130224149A1
申请日:
2012.08.21
申请国别(地区):
US
年份:
2013
代理人:
摘要：
This disclosure is directed to: (a) processes for preparing compounds and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV) (b) intermediates useful for the preparation of the compounds and salts (c) pharmaceutical compositions comprising the compounds or salts and (d) methods of use of such compositions.
